Search Media Items

Guiding questions for brain and spine tumor patients to ask their doctor about supportive care and coping resources.

This list of publications from the RAS Initiative reflects the balance between the public responsibilities of the National Cancer Institute and the requirements of our external partners.

Despite significant progress in the treatment of breast cancer, the transition of pre-invasive ductal carcinoma in situ (DCIS) to more aggressive invasive ductal carcinoma (IDC) remains unknown. No prognostic biomarkers can reliably predict the risk of progression from DCIS to IDC. Similar genomic profiles of matched pre-invasive DCIS and IDC suggests that the progression is not driven by genetic aberrations in DCIS cells, but microenvironmental factors, such as hypoxia and metabolic stress prevalent in DCIS, may drive the transition.

An NCI research update about research to investigate what factors play a role in “chemobrain” or cognitive impairment after cancer treatment.

Hoja informativa que trata sobre el formaldehído y su posible relación con el cáncer. Incluye recursos para consultar mayor información.

Information about the NCI-MATCH precision medicine trial, in which patients with advanced solid tumors and lymphomas are assigned to treatment arms based on the molecular profiles of their disease.

Hoja informativa que presenta estadísticas sobre el riesgo que tiene una mujer de padecer cáncer de seno (mama) e información sobre los factores de riesgo del cáncer de seno.

Anemia is a side effect of cancer treatments, including chemotherapy and radiation therapy. It can make women and men feel fatigued, dizzy, and short of breath. Learn how to manage fatigue caused by anemia during cancer treatment.

Information to help people evaluate the source and credibility of health information that they find in print or online.

Information about tests such as mammography and colonoscopy that may be used to screen for cancer in people without symptoms of disease.